Exagen (XGN) Current Assets (2018 - 2026)

Exagen has reported Current Assets for 9 years, with the latest figure at $43.6 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 34.08% year-over-year to $43.6 million; the trailing twelve-month figure through Mar 2026 stood at $43.6 million (up 34.08% YoY), and the FY2025 full-year result was $48.9 million, up 34.12% from the prior year.
• Current Assets for Q1 2026 stood at $43.6 million, down from $48.9 million in the prior quarter.
• The five-year high for Current Assets was $103.6 million in Q1 2022, with the low at $32.5 million in Q1 2025.
• Historically, Current Assets has averaged $55.5 million across 5 years, with a median of $48.9 million in 2023.
• Annual changes were most pronounced in 2023 — Current Assets slumped 41.85% — and 2025, when it jumped 47.9%.
• Exagen's Current Assets stood at $72.6 million in 2022, then slumped by 34.11% to $47.8 million in 2023, then slipped by 23.8% to $36.5 million in 2024, then jumped by 34.12% to $48.9 million in 2025, then declined by 10.86% to $43.6 million in 2026.
• The last three Current Assets figures came in at $43.6 million (Q1 2026), $48.9 million (Q4 2025), and $52.6 million (Q3 2025), per Business Quant data.